Pleural effusion

Derrame pleural

Published 2009-12-01

Open | Download
PDF (Spanish) FLIP
Issue
Vol. 21 No. 4 (2009)
Section
Revisión de tema
How to Cite
Pleural effusion.
rev. colomb. neumol. [Internet]. 2009 Dec. 1 [cited 2024 Nov. 23];21(4):175-8.
DOI
license
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Ninguna publicación, nacional o extranjera, podrá reproducir ni traducir sus artículos ni sus resúmenes sin previa autorización escrita del editor; sin embargo  los usuarios pueden descargar la información contenida en ella, pero deben darle atribución o reconocimiento de propiedad intelectual, deben usarlo tal como está, sin derivación alguna.

Andrés Jiménez Quijano
Fundación Santa Fe de Bogotá image/svg+xml
    Fidel Camacho Durán
    Universidad El Bosque image/svg+xml
      Show authors biography

      Andrés Jiménez Quijano,

      Cirujano de Tórax, Fundación Santa fe de Bogotá, Universidad El Bosque. Bogotá, Colombia

      Fidel Camacho Durán,

      MD, FACS. Profesor de Cirugía y Director del Programa de Postgrado de Cirugía de Tórax, Universidad El Bosque. Jefe de la Sección de Cirugía de Tórax, Fundación Santa Fe de Bogotá. Bogotá, Colombia

      The pleural effusion is defined as the abnormal accumulation of liquid in the pleural space that produces to itself for increase in the production or decrease of the drainage, common reasons in clinics disorders. Inside the reasons of the increase of the production we can enunciate an increase of the capillary pleural permeability, decrease of the oncotic pressure capillary and increase of the hydrostatic capillary pressure, there are less clear the reasons of the decrease of the drainage but are outlined the alteration of the lymphatic pleural contractibility , infiltration of vessels and lymphatic nodules for neoplasic diseases and alterations to pleural level that they should prevent that the this liquid touch the lymphatic pores.
      The objective of this review is the analysis of the physiological bases of the pleura and the production of the pleural liquid, the
      physiological aspects of the pleural effusion, the approach of the diagnose and the medical and surgical managing of the same one for the different reasons that produce it.

      Article visits 3443 | PDF visits 10657

      Downloads

      Download data is not yet available.
      1. Noppen M, Volume and cellular content of normal pleural fluid in humans examined in pleural lavage. Am J Resp Crit Care Med 2000; 162: 1023-6.
      2. Broaddus VC,Developmental changes in pleural liquid protein concentration in sheep.Am Rev Respir DFis 1991; 143: 38-41.
      3. Albertine KH, The structure of the pleura and its relationshipto pleural liquid dynamics in sheep . J Appl Physiol 1988; 64: 883- 92.
      4. Wiener JP, Protein egress and entry rates in pleural fluid and plasma in sheep, J Appl Physiol 1984; 56: 459-63.
      5. Shinoara H, Distribution of lymphatic stomata on the pleural surface of the thoracic cavity and the surface topography of the pleural mesotelium in the golden hamster. Respiration 2000; 67: 333-6.
      6. Leckie W, Physiological and pathological mechanisms governing fluid accumulation within the pleural space. Thorax 1970; 25: 256.
      7. Garrido V, Ferrer J, Arch Bronconeumol; 2006: Sep.
      8. Light RW,. Pleuraleffusion: the diagnostic separation of trasudates and exudates. Ann Intern Med 1972; 77: 507-13.
      9. John E, Discriminating Between Trasudates and Exudates. Clin Chest Med 2006; 27: 241-52.
      10. Ligh R, Gary YC, Text book of pleural disease; 2003: Cap 23: 310.
      11. Idell S, Abnormalities of pathways of exudative and fibrin turnover in the human pleura space. Am Rev Respir Dis 1991; 144: 187-94.
      12. Pothula V. Early aggressive surgical management of parapneumonic empyemas. Chest 1996; 105: 832-6.
      13. Chen KY, A 10 year experience with bacteriology of acute thoracic empyema. Chest 2000; 117: 1685-9.
      14. Heffner JE, Pleural fluid chemical analysis in parapneumonic effusions. A metanalysis. Am J Respir Crit Care Med 1995; 151: 1700-8.
      15. Colice GL, Medical and surgical treatment of parapneumonic effusions: an evidence-based guideline.Chest. 2000; 118: 1158-71.
      16. Cameron R. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of parapneumonic effusions and empyema. Cochrane Database Syst Rev 2004;(2): CD002312.
      17. Valdés L. Tuberculous pleurisy: A study of 254 cases. Arch Intern Med. 1998; 158: 2017-21
      18. Greco Sl. Adenosine deaminase and interferon gamma measurements for the diagnosis of tuberculous pleurisy: a meta-analysis. Int J Tuberc Lung Dis 2003; 7: 777-86.
      19. Burgess LJ. Combined use of pleural adenosine deaminase with lymphocyte/neutrophil ratio. Increased specificity for the diagnosis of tuberculosis pleuritis. Chest 1996; 109: 414-9.
      20. Valdés L. Diagnosis of tuberculous pleurisy using the biologic parameters adenosine deaminase, lysozyme, and interferon gamma. Chest 1993; 103: 458-65.
      21. Pai M, Flores LL. Nucleid acid amplification tests in the diagnosis of tuberculous pleuritis: a systematic review and metaanalysis. BMC Infectious Diseases 2004; 4: 6-20.
      22. Blumberg HM. American Thoracic Society / Centers for Diseases Control and Prevention/Infectious Diseases Society of America: Treatment of tuberculosis. Am J Respir Crit Care Med 2003; 167: 603-62.
      23. De Pablo A. Are pleural fluid parameters related to the development of residual thickening in tuberculosis? Chest 1997;112: 1293-7.
      24. Joe B. Putnam Jr, MD. Surg Clin N Am 2002; 82: 867-83.
      25. Sahn SA. Pleural fluid pH in malignant effusions. Diagnostic, prognostic, and therapeutic implications. Ann Intern Med. 1988; 108: 345-9.
      26. Antony VB. Management of malignant pleural effusions. Am J Respir Crit Care Med 2000; 162: 1987-2001.
      27. Antunes G. BTS guidelines for the management of malignant pleural effusions. Thorax 2003; 58(Suppl 2): II29-II38.
      28. Jacobi CA. Talc pleurodesis in recurrent pleural effusions. Langenbecks Arch Surg 1998; 383: 156-9.
      29. de Campos JR. Thoracoscopy talc poudrage: a 15-year experience. Chest 2001; 119: 801-6.
      30. Shaw P, Agarwal R. Pleurodesis for malignant pleural effusions. Cochrane Database Syst Rev 2004; (1):CD002916.
      31. Keane MP. Pleuropulmonary manifestations of systemic lupus erythematosus. Thorax 2000; 55: 159-66.
      32. Pertschuk LP. Acute pulmonary complications in systemic lupus erythematosus. Immunofluorescence and light microscopic study. Am J Clin Pathol 1987; 68: 553-7.
      33. Fernández C. Rheumatoid factor: diagnostic utility in pleural fluid. Eur Respir J 2003; 22: 191s.
      34. Romero-Candeira S. Influence of diuretics on the concentration of proteins and other components of pleural transudates in patients with heart failure. Am J Med 2001; 110: 681-6.
      35. Sadikot RT.Pleural fluid characteristics of patients with symptomatic pleural effusion after coronary artery bypass graft surgery.Arch Intern Med. 2000; 160: 2665-8.
      36. Kim S. Postcardiac injury syndrome. An immunologic pleural fluid analysis. Chest. 1996; 109: 570-2.
      37. Romero Candeira S. Biochemical and cytologic characteristics of pleural effusions secondary to pulmonary embolism. Chest 2002; 121: 465-9.
      38. Huggins JT. Drug-induced pleural disease. Clin Chest Med 2004; 25: 141-53.
      39. Dorigo O. Sex cord-stromal tumors of the ovary. UpTo-Date 2004; V12(2).
      40. Insler V. Classification and treatment of ovarian hyperstimulation syndrome. UpToDate 2004; V12(2)

      Information

      Journal history

      Keywords

      QR code

      Funding

      Support + Info: Here

       

       

      Directories and indexes

      Google Scholar profile

      Most read in the last 30 days

      Current Issue

      Sistema OJS 3.4.0.7 - Metabiblioteca |